# Biomat USA, Inc – FDA Inspection, Mar 8, 2018

Source: https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/1a28d544-e305-4769-895e-cc843acf5277
Source feed: FDA_Inspections

> FDA inspection 1043565 of Biomat USA, Inc, March 08, 2018. Classification: Voluntary Action Indicated (VAI). 2 citations under 21 CFR parts 606 and 630. Form 483 issued. 5 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1043565
- Company Name: Biomat USA, Inc
- Inspection Date: 2018-03-08
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 2

## Related Documents

- FDA Inspection 1204323 - 2023-04-21
- FDA Inspection 928923 - 2015-06-04
- FDA Inspection 859191 - 2013-12-17
- FDA Inspection 756113 - 2011-12-12
- FDA Inspection 550550 - 2008-12-04

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/elmina-e-akwo/ecd9066d-1647-4765-ad86-dbe5280241c5)
- [Company Rep](https://www.keypedia.com/people/everard-a-irish/840ad8d1-1e8a-4ade-9b3b-64f654754d17)

Company: https://www.keypedia.com/companies/biomat-usa-inc/37e1cb26-5d46-49d0-88df-dce9a2190b42

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d
